The Kennedy Institute at the University of Oxford recently hosted a dinner to celebrate and thank the Kennedy Trust for Rheumatology Research for its generous support and the endowment of two new professorships in translational medicine at the Institute.
The Oxford Microbiome Network (OMiN) aims to facilitate collaborations, knowledge sharing, and access to resources for microbiome researchers across Oxford. OMiN is co-led by researchers in the Kennedy Institute of Rheumatology and the Department of Biology. The network officially launched on 20th May 2024 with an event at Keble College.
Alan has spent two months at the Kennedy Institute as a guest of Professor Dame Fiona Powrie. During his visit he has spent his time collaborating with researchers at the Kennedy and other departments in the University, and mentoring young investigators on their career development.
Prof. Michael Dustin was one of 17 researchers from across Oxford's Medical Sciences and Maths, Physics and Life Sciences Divisions that have contributed to a new report on the future of healthcare, compiled by Citi Global Perspectives & Solutions (Citi GPS).
Dr Ashwin Jainarayanan has been selected to become a 2024 Schmidt Science Fellow \u2013 an honour bestowed on only 32 exceptional early career researchers worldwide.
A new programme of research led by Professor Claudia Monaco and funded by the British Heart Foundation aims to unpick the inflammatory processes behind cardiovascular disease so that immune-targeted therapies may be developed in future.
Connects-UK, a new pan-European network dedicated to advancing scientific collaborations between researchers in the European Union (EU) and the United Kingdom (UK), was officially launched at an event in London yesterday. The network, led by a diaspora of EU researchers working in the UK, seeks to bridge the gap created by Brexit and ensure that collaboration, innovative research, funding, and knowledge exchange continue to thrive in the post-Brexit era.
The immune system in the intestine maintains a careful balance, tolerating our long-term resident (commensal) gut bacteria while defending against invading pathogens. Under certain circumstances, dysregulation of our intestinal immune response to commensal and pathogenic microbes can drive inflammatory disease.
A new understanding of the PD-1 axis (programmed death cell) could help shape ongoing efforts to improve treatments for cancer and autoimmune diseases.
The Medical Research Council\u2019s Infections and Immunity Board (IIB) funds research into infectious human disease and disorders of the human immune system.
ZEISS is partnering with the University of Oxford bringing ground-breaking microscopy imaging equipment, and analysis tools, to advance the study of global health and disease.
Audrey G\u00e9rard has received \u00a3 1.5 million in funding from CRUK for a new research project to unravel the coevolving cancer and immune landscape.
A project led by Irina Udalova and co-led by Marco Fritzsche and Erinke van Grinsven, a senior postdoctoral fellow in the Udalova laboratory, has received funding from the Biotechnology and Biological Sciences Research Council (BBSRC) to uncover why and how neutrophils experience dramatic nuclear changes during their development, and the link between maladaptive neutrophil development and chronic inflammation.
A DPhil candidate at NDORMS, Caroline received the MRC Clinical Research Training Fellowship that has enabled her to further her research into head and neck cancer.
Two professorships in translational medicine have been endowed at the Kennedy Institute of Rheumatology thanks to a generous gift from the Kennedy Trust for Rheumatology Research.
A DPhil candidate at NDORMS, Tom Hosack received the MRC Clinical Research Training Fellowship to further his research into tissue tropism in PD-1 therapy in immune-mediated inflammatory diseases.
We welcome Adrien Hallou who has joined the Kennedy Institute as a new Principal Investigator. Adrien will be establishing his lab to better understand the role of mechanical forces on cell fate decisions and tissue dynamics in inflammatory diseases, with a particular focus on inflammatory skin diseases such as psoriasis or atopic dermatitis.
![\"Ovarian](\"https://www.kennedy.ox.ac.uk/news/cruk-funding-will-help-develop-new-targets-for-ovarian-cancer/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n